MediPharm Labs Stock (TSX: LABS) (OTCQX: MEDIF) - Investor Dashboard

➔ MediPharm Labs
TSX Ticker: LABS
Market Focus: Global
Classification: Processor
Country: Canada
Employees: 230 (12/31/19)
Established: 2015
CEO: Patrick McCutcheon

MediPharm Labs –  Management Team

Patrick McCutcheon, CEO

Before founding MediPharm Labs, Pat enjoyed a 15-year career in the pharmaceutical industry in top sales roles, successfully launching a wide range of medical products. He most recently worked at Jansen Pharmaceuticals (Johnson & Johnson) where he led the Hospital Division for Renal and Mental Health products. Pat’s foresight in creating a business that focuses on advanced cannabis concentrates bodes well for medical research, investors and consumers alike. Pat holds an Honors Bachelor of Science degree in biology from the University of Western Ontario.

Keith Strachan, President

Keith is a healthcare business development expert with experience in supply chain management, government ministries, public sector consultancy, compliance, licensing, and planning.

Bobby Kwon, Chief Financial Officer

Bobby has more than 25 years in the CPG, pharmaceutical, and retail industries. Before joining MediPharm Labs, he was the Senior Vice President of Canadian food and drug retail business Weston Group. Bobby has held senior roles in operations, finance, and strategic planning. He earned his MBA from Queen’s University and a BSc in biochemistry from the University of Toronton. He is also a CPA.

Sybil Taylor, Chief Marketing Officer

A 25-year marketing veteran, Sybil has brought premium consumer brands to life by developing innovative customer-focused marketing strategies. She launched Steam Whistle Pilsner in 2000 as a pioneering upstart and helped it grow to the largest craft beer brand in Canada. As CMO at Nuuvera Canada, Sybil was a senior contributor to this Canadian Cannabis start-up via strategic planning and brand development for medical and recreational brands. Sybil has been part of senior teams in two of Canada’s Best Managed Companies, and through CSR initiatives, she has brought numerous awards and public profile to her managed brands.

Braden Fenske, Chief Strategy Officer

In his role as Chief Strategy Officer, Braden is responsible for driving the company’s strategic corporate initiatives. He has 20 years of experience in the global healthcare industry and adult beverage space. Prior to joining MediPharm, Braden was the Group Product Director, Global Strategic marketing for Biosense Webster Inc., a J&J Company. He earned a bachelor’s degree in commerce from the University of Alberta.

Warren Everitt, CEO, Asia Pacific

Warren has 15 years of experience in sales, marketing, and consulting for major companies. Prior to joining MediPharm Labs, he built an Asia Pacific presence for a large international digital marketing agency.

Significant Insider Ownership

Patrick McCutcheon, CEO
9.33 million shares

Keith Strachan, VP, Business Development
7.48 million shares

Ahmed Shehata, General Counsel
3.17 million shares

Visit MediPharm Labs

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Medipharm Labs, Inc. is a client of NCV Media, LLC. Read our full disclaimer.